Sees overall market size of 50M-55M tests with greater than 50% of flu revenue coming from flu/COVID-19 combo test; Full year 2025 COVID-19 revenue of $110M-$140M; assumes no government contract revenue; No contribution from U.S. Savanna respiratory products in 2025.
Education
About Us
Working with TipRanks
Follow Us
